Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 34% ± 12% | |
lung | 12 studies | 24% ± 9% | |
uterus | 5 studies | 24% ± 12% | |
intestine | 4 studies | 22% ± 5% | |
breast | 4 studies | 24% ± 4% | |
kidney | 3 studies | 31% ± 9% | |
ovary | 3 studies | 25% ± 8% | |
lymph node | 3 studies | 27% ± 4% | |
liver | 3 studies | 31% ± 9% | |
skin | 3 studies | 33% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1653.28 | 459 / 459 | 94% | 14.59 | 1055 / 1118 |
lung | 100% | 2408.74 | 578 / 578 | 94% | 21.77 | 1089 / 1155 |
thymus | 98% | 719.49 | 637 / 653 | 94% | 18.79 | 568 / 605 |
uterus | 100% | 1370.89 | 170 / 170 | 89% | 61.26 | 407 / 459 |
skin | 100% | 2190.26 | 1809 / 1809 | 83% | 20.07 | 393 / 472 |
esophagus | 92% | 704.97 | 1335 / 1445 | 84% | 23.30 | 154 / 183 |
ovary | 100% | 1950.56 | 180 / 180 | 66% | 7.23 | 285 / 430 |
bladder | 90% | 1057.05 | 19 / 21 | 72% | 22.32 | 361 / 504 |
prostate | 87% | 606.01 | 214 / 245 | 59% | 4.27 | 297 / 502 |
kidney | 69% | 426.26 | 61 / 89 | 75% | 14.94 | 679 / 901 |
adrenal gland | 84% | 376.91 | 218 / 258 | 57% | 7.41 | 130 / 230 |
intestine | 90% | 649.10 | 865 / 966 | 51% | 5.47 | 271 / 527 |
stomach | 69% | 368.50 | 247 / 359 | 63% | 7.18 | 180 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.73 | 29 / 29 |
spleen | 100% | 2070.27 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2196.28 | 1202 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 5% | 16.17 | 16 / 328 | 93% | 18.57 | 166 / 178 |
tonsil | 0% | 0 | 0 / 0 | 98% | 49.21 | 44 / 45 |
liver | 46% | 227.04 | 105 / 226 | 50% | 5.07 | 205 / 406 |
peripheral blood | 94% | 1195.64 | 869 / 929 | 0% | 0 | 0 / 0 |
muscle | 90% | 697.45 | 719 / 803 | 0% | 0 | 0 / 0 |
brain | 30% | 138.13 | 786 / 2642 | 47% | 5.51 | 334 / 705 |
heart | 77% | 491.45 | 663 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 70% | 456.15 | 939 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 3.55 | 23 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051132 | Biological process | NK T cell activation |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLEC2B |
Protein name | C-type lectin domain family 2 member B C-type lectin domain family 2 member B (Activation-induced C-type lectin) (C-type lectin superfamily member 2) (IFN-alpha-2b-inducing-related protein 1) |
Synonyms | AICL CLECSF2 IFNRG1 |
Description | |
Accessions | ENST00000538152.1 ENST00000228438.3 Q92478 F5H631 |